EBC vs REGN · P/E 11, rev $112.6M vs P/E 14, rev $14.34B
Eastern Bankshares Inc (EBC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Eastern Bankshares Inc (EBC) is a banks - regional company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported EBC revenue for 2024-12-31 was $112.6M. Net income was $119.6M. Revenue was up 46.5% from 2023-12-31 to 2024-12-31. EBC currently screens at market cap $4.33B and trailing P/E 11.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
EBC currently screens at market cap $4.33B and trailing P/E 11.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the EBC and REGN stock pages for the full models.
Not investment advice.